700 patients110,866 observations180 daysLIVE

Patient P-02486

Synthetic patientMETA-24 · Day 171 · 25–34 · F · baseline S10Steering view · 3DOpen companion preview
Therapy response
Favorable
Tolerance
Improving
GI state
Deteriorating
Inflammatory state
Improving
Nutritional resilience
Improving
Discontinuation risk
15%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 META-24 startedBaseline state S10
  2. Day 63 ME-01 recommendedMonitoring Escalation ME-01
  3. Day 64 Patient acceptedStarted ME-01 in the companion
  4. Day 67 Deterioration detected before clinical escalationMonitoring Escalation ME-01

What changed?

Trajectory is tracking the baseline prediction.

Primary contributors, last 14 days
  • Toxicity-22
  • Inflammatory activity-7
  • Nutritional resilience+6
  • Treatment adherence+6
  • GI instability+5

What helped?

  • Monitoring Escalation ME-01Day 63
    Result: deterioration detected before clinical escalation
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

Active minutes
Wearable
51 min
stable · -2.2 vs previous 14 d
Sleep duration
Wearable
6.8 h
stable · +0.0 vs previous 14 d
Energy level
Daily log
7.1/10
stable · +0.2 vs previous 14 d
Steps
Wearable
6,140
stable · -125 vs previous 14 d
GI burden
Companion
14.5/100
improving · -6.8 vs previous 14 d
Adherence
Companion
95.5 %
stable · +0.1 vs previous 14 d
Sleep quality
Wearable
46.8/100
improving · +2.9 vs previous 14 d
Glucose, CGM daily mean
CGM
132 mg/dL
stable · -4.4 vs previous 14 d
This trajectory is doing well — what to keep, what to watch
Steering view →

Heading towards restoration · 94 from the failing basin, 9 from restoration.

Good elements to keep
  • Monitoring Escalation ME-01
    intervention · steering +20.7
  • Butyrate producers intact
    hidden · steering +7.5
  • Protein (supports)
    perturbation · steering +7.5
  • Daily walks resumed
    perturbation · steering +3.3
  • Protein
    supporter · GI -4.4 next day
Main detractors to watch
  • Alcohol
    perturbation · steering -8.1
  • Bacteroides fragilis elevated
    hidden · steering -7.4
  • Low-HRV stretch
    perturbation · steering -2.7
  • Dietary drift
    perturbation · steering -2.6
  • Alcohol
    detractor · GI +5 next day
State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

  • Alcohol
    +5detractor · 95%
  • Protein
    -4.4supporter · 95%
  • Simple carbohydrates
    -1.8no signal · 34%
  • Caffeine
    -1.3no signal · 29%
  • Histamine load
    +1.2no signal · 17%
  • Ultra-processed food
    -0.9no signal · 20%
  • Dietary fat load
    +0.3no signal · 15%
  • Insoluble fibre
    -0.1no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure
  • Mucosal barrier integrity 30
    • MicrobiomeAkkermansia low → thinner mucus layer
  • Butyrate / short-chain fatty acid production 25
    • MicrobiomeF. prausnitzii depleted
  • Autonomic recovery 25
    • WearableResting HR 73 bpm
  • Inflammatory signalling 20
    • MicrobiomeBacteroides fragilis expansion
DNA
Fictional pharmacogenomic panel
  • CYP2D6 Normal metabolizer
    Expected exposure
  • GLP1R rs6923761 A
    Altered receptor sensitivity
  • MTHFR C677T
    Reduced folate turnover
Microbiome
Shannon diversity 3.7 · butyrate capacity 52/100
  • Akkermansia muciniphilaLow
  • Faecalibacterium prausnitziiLow
  • Bacteroides fragilisHigh
  • Bifidobacterium longumNormal
  • EnterobacteriaceaeNormal
Wearable, last 14 days
daily evolution fed into the runtime
HRV
66 ms
Sleep
6.7 h
Steps
6,650
Resting HR
71 bpm
Daily log: GI score 15, nutritional resilience 71, adherence 96.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview
What to eat
  • Keep meals regular; three to four moderate portions spaced through the day
  • Include a cooked vegetable portion with each main meal
  • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
  • Eat slowly and stop at comfortable fullness — smaller volume, more often
What to do
  • Log the daily check-in; one line is enough
  • Keep the current walking rhythm
  • Keep the sleep window steady
  • Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
  • Take the dose at the same time relative to your evening meal
  • No additional supplements this week
  • Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

PatientSimilarityBaselineInterventionOutcomeResponse today
P-0255548%S01AD-05no change79
P-0260046%S0187
P-0213741%S0181
P-0225741%S0181
P-0228241%S01BR-03no change88
P-0220439%S0170
P-0259239%S0174
P-0227538%S0184
P-0234237%S0176
P-0213834%S0179
P-0262029%S01HY-01improved64
P-0221728%S0161